FGFR2 and intrahepatic cholangiocarcinoma: Among five patients with intrahepatic cholangiocarcinoma that had FGFR2 SNVs, two (C382R (patient 79) and extracellular domain in-frame deletion I291_Y308D del (patient 78)) experienced partial response and two (W290C (patient 75) and Y375C (patient 77)) had stable disease with PFS of 10.5 and 3.7 months, respectively.